Bulletin of Pharmaceutical & Medicinal Research2959-91992958-65182022-10-1331410.58398/0005.000013articleNazneen FatimaFaculty of Pharmacy, University of Sindh, Jamshoro, PakistanArtificial intelligence (AI) with the amalgamation of information technology is an important driver of transformation in every field of life, including the pharmaceutical industry. From the early stages of drug discovery, extraction, and formulation, followed by improvement and precision in manufacturing, AI has helped the pharmaceutical industry work more effectively and efficiently in the production of the highest-quality products. Machine learning (ML) algorithms can easily analyze large datasets in no time to identify potential pharmaceutically effective drugs, characteristics of experiments, parameters of testing, optimize clinical trial designs, and monitor pharmaceutical production processes in real time. These operations significantly reduce drug development time, costs, and effort; ease complexities; and improve safety and effectiveness, ultimately providing a competitive edge to many pharmaceutical companies across the globe. However, the incorporation of AI into pharmaceutical systems also presents significant challenges; for example, many pharmaceutical companies face issues with inconsistent or incomplete data, a lack of domain-specific technical human resources, and uncertain, debatable ethical concerns, particularly related to privacy, algorithmic fairness, and transparency in decision-making. The benefits and advantages of using AI may remain limited until pharmaceutical companies invest in high-quality data infrastructure, interdisciplinary training of professionals, and clear regulatory frameworks for procedures. This calls for vital collaboration and joint ventures among pharmaceutical companies, manufacturing units, research institutions, technology providers, informational technology houses, drug regulatory bodies, and academia to transform the pharmaceutical landscape by making drug development faster, cheaper, safer and more responsive to global health needs.